AlphaMadera's AlphaVal page classifies YD Bio Limited Ordinary Shares as a Stable Earnings Power business and values it using P/Adj-EPS × Normalized Multiple, then compares the result to the current market price to flag YDES as undervalued, fairly valued, or overvalued.

What is YD Bio Limited Ordinary Shares's fair value?

Fair value for YDES comes from a P/Adj-EPS × Normalized Multiple model -- the approach AlphaVal selected for this company's Stable Earnings Power classification. The live AlphaVal page shows bear, base, and bull scenarios alongside the key assumption behind each.

How does AlphaMadera value YDES?

AlphaVal routes each company to one of ten valuation archetypes based on its business model. YDES was classified as Stable Earnings Power and is valued using P/Adj-EPS × Normalized Multiple, built from YDES's most recent reported fundamentals.

YDES - YD Bio Limited Ordinary Shares

Price: -- --

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 40% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Overvalued Strong

Trading 655.9% above fair value

Current Price $4.77

Bear Case $0.54 88.7% downside ($0.54 - $4.77) / $4.77 = -88.7% $0.03 × 18x P/E

Fair Value $0.63 86.8% downside ($0.63 - $4.77) / $4.77 = -86.8% $0.03 × 21x P/E

Bull Case $0.72 84.9% downside ($0.72 - $4.77) / $4.77 = -84.9% $0.03 × 24x P/E

Adjust Assumptions

P/E Multiple

21.0x

Adjusted EPS

0.03$

Key Value Driver

Normalized P/E multiple (21x base case)

Terminal Value % of EV

Implied Market Multiple 158.7x

Market is pricing in (growth)

Plain-Language Summary

Applying a 21x P/E to adjusted EPS of $0.03, the base-case value is $0.63 per share.

Warnings

⚠ This stock is 78% below its 52-week high, with weak or declining earnings. That combination often signals real trouble, even though the valuation below is based on other fundamentals.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples